Relmada Therapeutics shares owned by Point72 Asset Management
Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Point72 Asset Management
from 13F filings
Historical chart of Point72 Asset Management investment in Relmada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Relmada Therapeutics held by Point72 Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Relmada Therapeutics by Point72 Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $905k | 187k | 4.83 |
| 2023-12-31 | $1.0M | 250k | 4.14 |
| 2023-06-30 | $12k | 4.7k | 2.46 |
| 2022-09-30 | $34M | 907k | 37.02 |
| 2022-06-30 | $24M | 1.3M | 18.99 |
| 2022-03-31 | $35M | 1.3M | 26.99 |
| 2021-12-31 | $21M | 946k | 22.53 |
| 2021-09-30 | $5.8M | 220k | 26.21 |
| 2021-06-30 | $6.2M | 195k | 32.01 |
| 2021-03-31 | $6.1M | 173k | 35.21 |
| 2020-12-31 | $9.1M | 285k | 32.07 |
| 2020-09-30 | $7.5M | 199k | 37.62 |
| 2020-06-30 | $7.4M | 165k | 44.75 |
| 2019-12-31 | $5.3M | 137k | 39.00 |